Summary This chapter provides the basic characteristics, side effects/toxicity, drug interactions, and dosing of the Epclusa (Sofosbuvir + Velpatasvir). Sofosbuvir is a nucleotide reverse transcriptase inhibitor for hepatitis C NS5B polymerase. Velpatasvir is an NS5A inhibitor. Sofosbuvir ...
Epclusa Dosing information Adult Epclusa Dose for Chronic Hepatitis C Dose:The usual adult Epclusa dose is sofosbuvir 400 mg-velpatasvir 100 mg orally once a day. Recommended Regimen and Duration of Therapy: Therapy-naive and therapy-experienced, without cirrhosis and with compensated cirrhosis ...